Petra Jonsson Razdan, MD
Allergy & Immunology · Lincoln, NENPI 1548438880
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,039 of the $7,280 with a category attached, or 69.2%. 34 manufacturers reported payments, led by Consortium Of Independent Immunology Clinics, LLC at 29.4% of the total. Reporting peaked in 2024 at $2,968 and has fallen 52.3% since, to $1,416 in 2025. That places this record below the midpoint for allergy & immunology clinicians in NE, where the typical reported total is $7,833.
Across 269 payments — averaging $27.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Consortium Of Independent Immunology Clinics, LLC$2K
- Sanofi$1K
- AstraZeneca$1K
- Takeda Pharmaceuticals U.S.A., Inc.$346
- CSL Behring$255
- Amgen$199
- plus $2K from 28 others
Across 2 payments — averaging $359.86 each. An ownership or investment interest held by the physician or an immediate family member.
- Consortium Of Independent Immunology Clinics, LLC$720
What the payments were for
- Consulting fees$2,14329%
- Food & beverage$5,03969%
- Education$981%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Consortium Of Independent Immunology Clinics, LLC | 2 | $2,143 |
| Sanofi | 71 | $1,289 |
| AstraZeneca | 52 | $1,231 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $346 |
| CSL Behring | 10 | $255 |
| Amgen(2 entities) | 11 | $199 |
| Grifols USA, LLC | 10 | $196 |
| Novartis | 11 | $193 |
| AbbVie | 11 | $187 |
| GSK | 11 | $142 |
| Pfizer | 6 | $118 |
| Regeneron Healthcare Solutions, Inc. | 5 | $106 |
| Hospira, Inc. | 6 | $101 |
| Genentech USA, Inc. | 7 | $86 |
| Sanofi-aventis U.S. LLC | 1 | $85 |
| Optinose US, Inc. | 3 | $61 |
| Pharming Healthcare, Inc. | 4 | $61 |
| Kaleo, Inc. | 4 | $52 |
| Biocryst US Sales Co., LLC | 4 | $51 |
| Shire North American Group Inc | 4 | $49 |
| Blueprint Medicines Corporation | 2 | $49 |
| Boehringer Ingelheim | 3 | $41 |
| Aimmune Therapeutics, Inc. | 2 | $34 |
| LEO Pharma Inc. | 2 | $32 |
| Sirtex Medical Inc | 1 | $32 |
| Bio Products Laboratory USA, Inc. | 1 | $24 |
| Philips North America LLC | 1 | $21 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| Mylan Specialty L.p. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $14 |
| Incyte Corporation | 1 | $13 |
| Alk-abello, Inc | 1 | $12 |
| Biocryst Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,280 in reported general payments places this provider in the 45th percentile of 21 allergy & immunology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 105 | $288,252 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 47 | $119,477 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 94 | $79,253 |
| XolairOmalizumab | 20 | $61,989 |
| Dupixent SyringeDupilumab | 14 | $61,809 |
| Spiriva RespimatTiotropium Bromide | 31 | $26,681 |
| Breo ElliptaFluticasone/Vilanterol | 60 | $25,402 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 30 | $21,987 |
| SymbicortBudesonide/Formoterol Fumarate | 86 | $21,386 |
| DuleraMometasone/Formoterol | 20 | $9,937 |
| Azelastine Hcl | 240 | $7,455 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 45 | $7,072 |
| Qvar RedihalerBeclomethasone Dipropionate | 21 | $6,991 |
| Advair HfaFluticasone Propion/Salmeterol | 20 | $6,642 |
| Arnuity ElliptaFluticasone Furoate | 15 | $6,411 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Grifols USA, LLCGamunex-C | $196 | $288,252105 claims |
| CSL BehringHizentra | $255 | $119,47747 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $142 | $111,066169 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,231 | $43,373116 claims |
| Boehringer IngelheimSpiriva Respimat | $41 | $26,68131 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 21 allergy & immunology providers in Nebraska.
Other allergy & immunology in Lincoln
- Robert SzalewskiLincoln$78K
- Suzan PaeLincoln$8K
- Hannah NeuhausLincoln$3K
- Kevin MurphyBoys Town$1.1M
- James TracyOmaha$104K
- Linda FordBellevue$78K
- Roger KobayashiOmaha$45K
- Mitchell PitlickOmaha$26K
- James FriedlanderOmaha$22K
- Brett KettelhutOmaha$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.